Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2023-06-07 00:00:00 ET · period of report 2023-06-06 · accession 0001209191-23-035263 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-07 | 2023-06-06+ | PCRX | SLONIN JONATHAN | Chief Clinical Off | S - Sale | $38.42 | -961 | 36.3K | -3% | -$36.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-06 | S | D | 471 | $38.99 | 36,813 | D | — | — | (F1) Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. (F2) Includes 205 shares of common stock acquired under the issuer's employee stock purchase plan in December 2022. |
| 2 | Common | Common Stock | 2023-06-07 | S | D | 490 | $37.87 | 36,323 | D | — | — | (F1) Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. |